APA (7th ed.) Citation

Saker, D., Sencar, L., Coskun, G., Sapmaz Ercakalli, T., Yilmaz, D. M., & Polat, S. (2024). Galantamine and wedelolactone combined treatment suppresses LPS-induced NLRP3 inflammasome activation in microglial cells. Immunopharmacology & Immunotoxicology, 46(6), 805. https://doi.org/10.1080/08923973.2024.2405579

Chicago Style (17th ed.) Citation

Saker, Dilek, Leman Sencar, Gulfidan Coskun, Tugce Sapmaz Ercakalli, Dervis Mansuri Yilmaz, and Sait Polat. "Galantamine and Wedelolactone Combined Treatment Suppresses LPS-induced NLRP3 Inflammasome Activation in Microglial Cells." Immunopharmacology & Immunotoxicology 46, no. 6 (2024): 805. https://doi.org/10.1080/08923973.2024.2405579.

MLA (9th ed.) Citation

Saker, Dilek, et al. "Galantamine and Wedelolactone Combined Treatment Suppresses LPS-induced NLRP3 Inflammasome Activation in Microglial Cells." Immunopharmacology & Immunotoxicology, vol. 46, no. 6, 2024, p. 805, https://doi.org/10.1080/08923973.2024.2405579.